CubaPLUS Magazine

On July 1, 1986, the Center for Genetic Engineering and Biotechnology (CIGB) was founded in the Cuban capital, a few years later a similar one in Camagüey and scientific institutions such as the Center for Molecular Immunology, the Institute of Immunoassay... that would work in the same line than the first, achieving many successes.

Today, when the efficacy of the Cuban vaccines against COVID-19, called Soberana 01, 02, Plus and Abdala, with approved and safe application in the emergency phase, is already confirmed and the Mambisa is advancing with great efficiency, Cuba continues to establish itself in the field of scientific research and in the biotechnology industry, with a well-respected previous path.

The vaccines created by the science of the archipelago have been decisive for the nation to come under control of the terrible pandemic and could even provide solidarity aid to countries on different continents, including Europe. Cuba currently accumulates a prestige recognized by the peoples and personalities and world institutions that are benchmarks in these fields.

In addition, contributions from the CIGB, as well as from the Finlay Institute, are the obtaining of state-of-the-art drugs in this way, including one for therapeutic use for the treatment of lung, neck and head cancer, which has achieved amazing results in tumor remission. of the respiratory organ, in very advanced stages.

Also, among the nation's star drugs are the recombinant Heberferon Alfa 2b, used with great efficacy in melanomas, the famous Heberprot P, in diabetic foot therapy, and another one has recently appeared, generating great expectations: NeuroEpo, the which is a great hope for the possible cure or slowing down of Alzheimer's.